Details for Patent: 9,035,074
✉ Email this page to a colleague
Which drugs does patent 9,035,074 protect, and when does it expire?
Patent 9,035,074 protects CIBINQO and is included in one NDA.
This patent has sixty-five patent family members in forty-four countries.
Summary for Patent: 9,035,074
| Title: | Pyrrolo[2,3-D]pyrimidine derivatives |
| Abstract: | Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them. |
| Inventor(s): | Brown; Matthew Frank (Stonington, CT), Fenwick; Ashley Edward (Richland, MI), Flanagan; Mark Edward (Gales Ferry, CT), Gonzales; Andrea (Kalamazoo, MI), Johnson; Timothy Allan (Vicksburg, MI), Kaila; Neelu (Lexington, MA), Mitton-Fry; Mark J. (Granville, OH), Strohbach; Joseph Walter (Wentzville, MO), TenBrink; Ruth E. (Labadie, MO), Trzupek; John David (Medford, MA), Unwalla; Rayomand Jal (Bedford, MA), Vazquez; Michael L. (Billerica, MA), Parikh; Mihir D. (Groton, CT) |
| Assignee: | Pfizer Inc. (New York, NY) |
| Application Number: | 14/183,946 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 9,035,074
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | CIBINQO | abrocitinib | TABLET;ORAL | 213871-001 | Jan 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Pfizer | CIBINQO | abrocitinib | TABLET;ORAL | 213871-002 | Jan 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Pfizer | CIBINQO | abrocitinib | TABLET;ORAL | 213871-003 | Jan 14, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,035,074
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2958921 | ⤷ Sign Up | 301155 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2958921 | ⤷ Sign Up | PA2022502 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2958921 | ⤷ Sign Up | CA 2022 00003 | Denmark | ⤷ Sign Up |
| European Patent Office | 2958921 | ⤷ Sign Up | 122022000007 | Germany | ⤷ Sign Up |
| European Patent Office | 2958921 | ⤷ Sign Up | 2022C/505 | Belgium | ⤷ Sign Up |
| European Patent Office | 2958921 | ⤷ Sign Up | LUC00261 | Luxembourg | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
